Lexicon Pharmaceuticals Files 8-K on Financials
Ticker: LXRX · Form: 8-K · Filed: May 13, 2025
Sentiment: neutral
Topics: financial-condition, financial-statements, results-of-operations
Related Tickers: LXRX
TL;DR
LEXICON PHARMACEUTICALS (LXRX) FILED AN 8-K ON MAY 13, 2025, PROVIDING FINANCIAL UPDATES.
AI Summary
Lexicon Pharmaceuticals, Inc. filed an 8-K on May 13, 2025, reporting on its results of operations and financial condition, as well as filing financial statements and exhibits. The filing pertains to the period ending May 13, 2025.
Why It Matters
This 8-K filing provides an update on Lexicon Pharmaceuticals' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- Lexicon Pharmaceuticals, Inc. (company) — Registrant
- May 13, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 2818633000 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
What is the exact date of the report?
The date of the report is May 13, 2025.
What is the company's principal executive office address?
The address is 2445 Technology Forest Blvd., 11th Floor, The Woodlands, Texas 77381.
What is Lexicon Pharmaceuticals' SEC File Number?
The SEC File Number is 000-30111.
What is the SIC code for Lexicon Pharmaceuticals?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding LEXICON PHARMACEUTICALS, INC. (LXRX).